Menu UF Health Home Menu
 

2012 Publications

Babette Brumback, Ph.D.

Classen S, Wen P, Velozo C, Bédard M, Winter SM, Brumback B Lanford DN (2012). “Psychometrics of the  Self-Report  Safe  Driving Behavior Measure for  Older Adults.” American Journal of Occupational Therapy, 66: 233-241.

He Z*,  Brumback BA  (2012). “An Equivalence of Conditional and Unconditional Maximum Likelihood Estimators via Infinite Replication of Observations.” Communications in Statistics – Theory and Methods, in press.

Brumback BA, Dailey  AB,  Zheng  HW*  (2012).  “Adjusting for Confounding by Neighborhood Using a Proportional Odds Model and Complex Survey Data.” American Journal of Epidemiology, 175(11): 1133-1141.

Freeman MC, Greene LE, Dreibelbis R, Saboori S, Muga R, Brumback B, Rheingans R (2012).   “Assessing the impact of a school-based water treatment, hygiene and sanitation programme on  pupil  absence  in  Nyanza  Province,  Kenya:  a  cluster-randomized  trial.” Tropical Medicine and International Health, 17(3): 380-391.

Price CC, Mitchel S, Brumback B, Tanner J, Schmalfuss I, Lamar M, Giovannetti T, Heilman  KM, Libon DJ  (2012).   “MRI-Leukoariosis Thresholds and the Phenotypic Expression of Dementia.” Neurology, 79(8): 734-740.

Gerhard T, Delaney JAC, Shuster J, Brumback B, Johnson JA, Pepine C, Winterstein AG (2012). Estimating effects of antihypertensive therapy on adverse cardiovascular outcomes in the presence of time-dependent confounding by blood pressure.”  BMC Medical Research Methodology, 12: 119.

Amy Cantrell, Ph.D.

Nicole J. Tester, Hugues Barbeau, Dena R. Howland, Amy Cantrell, Andrea L. Behrman, Arm and leg coordination during treadmill walking in individuals with motor incomplete spinal cord injury: A preliminary study, Gait & Posture  36 (2012), 49-55.

Myron Chang, Ph.D.

Chang MN, J Shuster, and W Hou (2012). Improved two-stage tests for stratified phase II cancer clinical trials. Statistics in Medicine.

Draganov PV,  MN  Chang,  A  Alkhasawneh, LR  Dixon,  J Lieb, et al (2012).  Randomized controlled trial of standard versus jumbo biopsy forceps for polypectomy of  small  sessile colorectal  polyps.  Gastrointestinal Endoscopy, 75:118-126.

Carilli, AR, MW Sugrue, EH Rosenau, MN Chang, D Fisk, M Medei- Hill, K Williams, L Wiggins, and JR Wingard (2012). African American adult donors respond to granulocyte-colony-stimulating factor with neutrophil and progenitor cell yields comparable to those of Caucasian and Hispanic donors. Transfusion, 52:166-172.

Rosenau EH, MW Sugrue, M Holler, D Fisk, SS Kelly, MN Chang,  W Hou,  L Eldjerou, W  Slayton,  CR  Cogle, and  JR Wingard (2012). Characteristics of thawed autologous umbilical cord blood. Transfusion, 52(10): 2234-2242.

Chaleff S, CA Hurwitz,  MN Chang, G Dahl, TA. Alonzo, H. Weinstein (2012). Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with relapsed acute myeloid leukemia:  A Pediatric Oncology Group Study. British Journal of Hematology, 156: 649-655.

Urquidi V, J  Kim,  MN Chang, Y Dai, ED Wolfson, S Goodison, CJ Rosser (2012). IL-8 as a urinary biomarker for the Detection of Bladder Cancer. BMC Urology, 12:12, 10.1186/1471-2490-12-12

Urquidi V, J Kim,  MN Chang, Y Dai, CJ Rosser, S Goodison (2012). CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer. PLoS ONE, 7(5): e37797, doi: 10.1371.

Urquidi V, S Goodison, J Kim,  MN Chang, Dai Y, CJ Rosser (2012). Vascular Endothelial Growth Factor, Carbonic Anhydrase 9, and Angiogenin as Urinary Biomarkers for Bladder Cancer Detection. Urology, 79(5): 1185.e1-1185.e6.

Logan HL, SL Tomar, MN Chang, GE Turner, WM Mendenhall, CE Riggs (2012). Comparison group for 5-year oral and pharyngeal cancer survivors: Two methods. BMC Medical Research Methodology, 12(63): 10.1186/1471-2288-12-63.

Goodison S,  MN Chang, Y Dai, S Ross, V Urquidi, CJ Rosser (2012).  Multi-analyte assay for the non-invasive detection of bladder cancer. PLoS One. 7(10): e47469.

Yueh-Yun Chi, PhD

Chi YY, Gribbin  M,  Lamers  Y,  Gregory  JF,  and  Muller  KE  (2012)  Global Hypothesis   Testing   for   High   Dimensional   Repeated   Measures   Outcomes, Statistics in Medicine, 31, 724-742. PMCID: PMC3396026.

Chi YY  (2012)  Overview  of  Multivariate  Methods.   Wiley Interdisciplinary Reviews: Computational Statistic s, 4, 35-47.

Zhu H, Ibrahim JG, Chi YY, and Tang N (2012) Bayesian Influence Measures for Joint Models for Longitudinal and Survival Data, Biometrics, 68, 954-964. PMCID: PMC 3496431.

Zhao M, Lamers Y, Ralat M, Coats B, Chi YY, Muller KE, Bain JR, Shankar MN, Newgard CB, Stacpoole PW, and Gregory JF (2012) Marginal Vitamin B -6 Deficiency   Decreases    Plasma    n -3    and    n-6    Polyunsaturated    Fatty   Acid Concentrations  in  Health  Men  and  Women,  Journal of  Nutrition ,  142,  1791- 1797. PMCID: PMC 3442793.

Stahl   JM,   Chi   YY,   and   Friedman   WA   (2012)   Repeat Radiosurgery for Intracranial Arteriovenous Malformations, Neurosurgery, 70, 150-154.  PubMed PMID 31743357.

Rahman M, Cox JB, Chi YY, Carter JH, and Friedman WA (2012)  Radiographic Response of Brain Metastasis after Linear Accelerator Radiosurgery, St ereotactic and Functional Neurosurgery, 90, 69 -78. PubMed PMID 22286386.

Meenakshi Devidas, Ph.D.

Salzer WL, Jones TJ,  Devidas M, Hilden JM, Winick N, Hunger S, Carroll WL, Camitta B, Dreyer ZE.  Modifications to induction therapy decrease risk of early death in infants with acute  lymphoblastic leukemia treated on Children’s Oncology Group P9407. Pediatric Blood & Cancer, 2012 Nov; 59(5):834-9. doi: 10.1002/pbc.24132. Epub 2012 Apr 5.

Yang JJ, Cheng C, Devidas M, Cao X, Campana D, Yang W, Fan Y, Neale G, Cox N,Scheet P, Borowitz MJ, Winick NJ, Martin PL, Bowman WP, Camitta B, Reaman GH, Carroll WL, Willman CL, Hunger SP, Evans WE, Pui CH, Loh M, Relling MV. Genome- wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Blood. 2012 Nov 15; 120(20):4197-204. doi: 10.1182/ Blood-2012-07-440107. Epub 2012 Sep 24.

Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, Reaman GH, Carroll WL. Reply to A. Bleyer et al. Journal of Clinical Oncology, November 10, 2012 vol. 30 no. 32 4038-4039, Epub October 1, 2012, doi: 10.1200/JCO.2012. 45.1070

Ryba T (g), Battaglia D, Chang BH, Shirley JW, Buckley Q, Pope BD, Devidas M, Druker BJ, Gilbert DM. Abnormal developmental control of replication-timing domains in pediatric acute   lymphoblastic leukemia. Genome Research 2012 Oct; 22(10):1833-44. doi: 10.1101/gr.138511.112. Epub 2012 May 24.

Messinger YH, Higgins RR, Devidas M, Hunger SP, Carroll AJ, Heerema NA. Pediatric acute lymphoblastic leukemia with a t(8;14)(q11.2;q32): B-cell disease with a high proportion of Down syndrome: a Children’s Oncology Group study. Cancer Genetics 2012 Sept; 205(9):453-8. doi: 10.1016/j.cancergen.2012.07.016.

Mattano LA Jr, Devidas M, Nachman JB, Sather HN, Hunger SP, Steinherz PG, Gaynon PS, Seibel NL; Children’s Oncology Group. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncology 2012 Sep; 13(9):906-15. Epub 2012 Aug 15.

Roberts KG, Morin RD, Zhang J, Hirst M, Zhao Y, Su X, Chen SC, Payne-Turner D,Churchman ML, Harvey RC, Chen X, Kasap C, Yan C, Becksfort J, Finney RP, Teachey DT, Maude SL, Tse K, Moore R, Jones S, Mungall K, Birol I, Edmonson MN, Hu Y, Buetow KE, Chen IM, Carroll WL, Wei L, Ma J, Kleppe M, Levine RL, Garcia-Manero G, Larsen E, Shah NP, Devidas M, Reaman G, Smith M, Paugh SW, Evans WE, Grupp SA, Jeha S, Pui CH, Gerhard DS, Downing JR, Willman CL, Loh M, Hunger SP, Marra MA, Mullighan CG. Genetic  alterations  activating  kinase  and  cytokine  receptor  signaling  in  high-risk  acute lymphoblastic leukemia. Cancer Cell. 2012 Aug 14; 22(2):153-66. doi: 10.1016/j.ccr.2012.06.005.

Dunsmore KP, Devidas M, Linda SB, Borowitz MJ, Winick N, Hunger SP, Carroll WL, Camitta BM. Pilot study of nelarabine in combination with intensive chemotherapy in high- risk  T-cell acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Journal of Clinical Oncology 2012 Aug 1; 30(22):2753-9. doi: 10.1200/JCO.2011.40.8724. Epub 2012 Jun 25.

Ebb D, Meyers P, Grier H, Bernstein M, Gorlick R, Lipshultz SE, Krailo M, Devidas M, Barkauskas DA, Siegal GP, Ferguson WS, Letson GD, Marcus K, Goorin A, Beardsley P, Marina  N. Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment  of metastatic  osteosarcoma  with  human  epidermal  growth  factor  receptor  2 overexpression: a report from the children’s oncology group. Journal of Clinical Oncology. 2012 Jul 10; 30(20):2545-51. doi:10.1200/JCO.2011.37.4546.

Sepe DM (f), McWilliams T, Chen J, Kershenbaum A, Zhao H, La M, Devidas M, Lange B, Rebbeck TR, Aplenc R. Germline genetic variation and treatment response on CCG-1891. Pediatric Blood & Cancer. 2012 May; 58(5):695-700. doi: 10.1002/pbc.23192.

Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, Reaman GH, Carroll WL. Improved survival for children and adolescents with acute lymphoblastic leukemia from  1990-2005:  A  report  from  the  Children’s  Oncology  Group. Journal of Clinical Oncology, 2012 May 10; 30(14):1663-9. doi:10.1200/JCO.2011.37.8018. Epub 2012 Mar 12.

Schrappe M, Hunger S, Pui C-H, Saha V, Gaynon P, Baruchel A, Masera G, Otten J, Tsuchida M, Versluys AB, Escherich G, Heymans M, Silverman L, Horibe K, Mann G, Camitta B, Harbott J, Riehm H, Richards S, Devidas M, Zimmermann M. Outcome after induction failure in childhood acute lymphoblastic leukemia. New England Journal of Medicine, 366: 1371-1381, 2012.

Chen I-M, Harvey RC, Mullighan CG, Gatier-Foster J, Wharton W, Kang H, Borowitz MJ, Camitta BM, Carroll AJ, Devidas M, Pullen DJ, Payne-Turner D, Tasian SK, Reshmi S, Cottrell  CE, Reaman GH, Bowman WP, Carroll WL, Loh M, Winick NJ, Hunger SP, Willman CL.  Outcome Modeling with CRLF2, IKZF1, JAK and Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study. Blood, 2012 Apr 12;119(15):3512-22. doi:10.1182/ Blood-2011-11-394221. Epub 2012 Feb 24.

Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen S-C, Wei L, Collins-Underwood JR, Ma J, Roberts KG, Pounds  SB,  Ulyanov  A,  Becksfort  J,  Gupta  P,  Huether  R,  Kriwacki  RW,  Parker  M, McGoldrick D, Zhao D, Alford D, Espy S, Bobba KC, Song G, Pei D, Cheng C, Roberts S, Barbato MI, Campana D, Coustan-Smith E, Shurtleff SA, Raimondi SC, Kleppe M, Cools J, Shimano KA, Hermiston ML, Doulatov S, Eppert K, Laurenti El Notta F, Dick JE, Basso G, Hunger SP, Loh ML, Devidas M, Wood B, Winter S, Dunsmore SP, Fulton RS, Fulton LL, Hong X, Harris CC, Dooling DJ, Ochoa K, Johnson KJ, Obenaur JC, Evans WE, Pui C-H, Naeve CW, Ley TJ, Mardis ER, Wilson RK, Downing JR, Mullighan CG. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature, 481:157-163, 2012 [Epub 2012 Jan 12].

Xu H (f), Cheng C, Devidas M, Pei D, Fan Y, Yang W, Neale G, Scheet P, Burchard EG, Torgerson DG, Eng C, Dean M, Antillon F, Winick NJ, Martin PL, Willman CL, Camitta BM,  Reaman GH, Carroll WL, Loh ML, Evans WE, Pui C-H, Hunger SP, Relling MV, Yang JJ.  ARID5B Genetic Polymorphisms Contribute to Racial Disparities in the Incidence and Treatment Oucome of Childhood Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 30: 751-757, 2012 [Epub 2012 Jan 30].

Salzer WL, Winick NJ, Wacker P, Lu X,  Devidas M, Shuster JJ, Mahoney DH, Lauer SJ, Camitta BM. Plasma Methotrexate, Red   Blood Cell Methotrexate, and Red   Blood Cell Folate Values and Outcome in Children With Precursor B-acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group. Journal of Pediatric Hematology/Oncology. January 2012 – Volume 34 – Issue 1 – p e1–e7, doi: 10.1097/MPH.0b013e31820ee239

Caniza MA, Hunger SP, Schrauder A, Valsecchi MG, Pui C-H, Masera G, and members of the International Study Group of Childhood ALL (the “Ponte di Legno ALL Working Group”). The controversy of varicella vaccination in children with acute lymphoblastic leukemia. Pediatric   Blood & Cancer, 58: 12-16, 2012 [Epub 2011 Sep 16]. (Devidas, M is a member of the Ponte di Legno ALL Working Group).

Kang H, Wilson CS, Harvey RC, Chen I-M, Murphy MH, Atlas SR, Bedrick EJ, Devidas M, Carroll AJ, Robinson BW, Stam RW Valsecchi MG, PhD7, Pieters R, Heerema NA, Hilden JA, Dreyer ZE, Camitta B, Winick N, Carroll WL. Felix CA, Reaman GH, Hunger SP, Willman CL.  Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children’s Oncology Group Study.   Blood, 119: 1872-1881, 2012 [Epub 2011 Dec 30].

Alsina A, Makris AM (g), Pak SH, Franco ES,  Devidas M, Huffer FW, Kemmer NM, Neff The detrimental effect of patient’s geography from the Liver Transplant Center: Impact of Hepatitis C. Hepatology October 2012, 56, 505A-505A.

Mattano LA, Devidas M, Winick N, Raetz EA, Hunger SP, Carroll WL, Larsen EC. Effects of dexamethasone (DEX) vs prednisone (PDN) and high-dose methotrexate (HD-MTX) vs Capizzi methotrexate/asparaginase (C-MTX/ASNase) on osteonecrosis (ON) incidence in children and young adults with high risk acute lymphoblastic leukemia (HR‑ALL): a report of the Children’s Oncology Group (COG) Study AALL0232.   Blood, Dec 2012; 120 (21) 665: (Oral presentation at ASH 2012).

Slayton WB, Schultz KR, Jones T, Raetz E, Devidas M, Pulsipher MA, Loh M, Chang BH, Carroll WL, Borowitz MJ, Silverman LB, Brown VI, Winick N, Carroll AJ, Heerema NA, Gastier-Foster JM, Wood BL, Mizrahy SL, Merchant TE, Hunger SP.  Continuous Dose Dasatinib Is Safe and Feasible in Combination with Intensive Chemotherapy in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Children’s Oncology Group (COG) Trial AALL0622.   Blood, Dec 2012; 120 (21) 137: (Oral presentation at ASH 2012).

Rabin KR, Mason CC, Gurusiddappa S, Leung HE, Morrison DJ, Bhojwani D, Barnette P, South ST, Miles RR, Devidas M, Pession A, Basso G, Potter NE, Kearney L, Moorman AV, Raimondi SC, Jeha S, Pui CH, Carroll WL, Loh ML, Hunger SP, Mulligan CG, Schiffman JD. IKZF1 and 22q11.22 Deletions and PDGFRA Gains Are Associated with Poor Outcome in Down Syndrome Acute Lymphoblastic Leukemia.   Blood, Dec 2012; 120 (21) 289: (Oral presentation at ASH 2012).

Schmiegelow K, Levinsen MF, Attarbaschi A, Baruchel A, Devidas M, Escherich G, Gibson B, Heydrich C, Horibe K, Ishida Y, Liang DC, Locatelli F, Michel G, Pieters R, Piette C, Pui CH, Raimondi S, Silverman L, Stanulla M, Stark B, Winick N, Valsecchi MG. Second Neoplasms after treatment of Childhood Acute Lymphoblastic Leukemia.    Blood, Dec 2012; 120 (21) 666: (Oral presentation at ASH 2012).

Yang JJ, Xu H (f), Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, Pei D, Scheet P, Burchard EG, Eng C, Huntsman S, Torgerson DG, Dean M, Winick N, Martin PL, Camitta B, Bowman WP, Willman CL, Carroll WL, Mulligan CG, Bhojwani D, Hunger SP, Pui CH, Evans WE, Relling MV, Loh ML. 877 Genome-Wide Association Study Identifies a Novel Susceptibility Locus At 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethnically diverse populations.   Blood, Dec 2012; 120 (21) 877: (Oral presentation at ASH 2012).

Gawad C, Borowitz MJ, Dahl GV, Devidas M, Faham M, Moorhead M, Wood BL, Zheng J, Loh ML, Lacayo NJ. Comparison of High-Throughput sequencing and Flow cytometry for measuring Minimal Residual Disease in pediatric Acute Lymphoblastic Leukemia: A Children’s Oncology Group Cohort.   Blood, Dec 2012; 120 (21) 1440: (Poster presentation at ASH 2012).

Ramsey LB, Panetta JC, Smith C, Yang W, Fan Y, Winick N, Martin PL, Cheng C, Devidas M, Pui CH, Evans WE, Hunger SP, Loh ML, Relling MV. A Genome-wide Analysis of Variants influencing Methotrexate clearance replicates SLCO1B1.   Blood, Dec 2012; 120 (21) 2466: (Poster presentation at ASH 2012).

Matlawska-Wasowska K (f), Harvey RC, Chen IM, Willman CL, Heerema NA, Carroll AJ, Devidas M, Loh ML, Hunger SP, Raetz EA, Mulligan CG, Asselin B, Winick N, Carroll WL, Larson RS, Dunsmore KP, Winter SS.  Expression profiling for MEIS1 and HOXA9/10 identifies an increased incidence of MLL Rearrangements in T-ALL: A Children’s Oncology Group Study.    Blood, Dec 2012; 120 (21) 2505: (Poster presentation at ASH 2012).

Harvey RC, Wood BL, Chen IM, Doral M, Yu K, Devidas M, Gastier-Foster JM, Larsen EC, Maloney KW, Raetz EA, Winick N, Carroll WL, Hunger SP, Willman CL, Loh ML. Identification of CRLF2 Genomic lesions in patients with pediatric B-precursor Acute Lymphoblastic Leukemia (BCP ALL) by Flow Cytometry or Quantitative RT-PCR: A Children’s Oncology Group (COG) Study.   Blood, Dec 2012; 120 (21) 2529: (Poster presentation at ASH 2012).

Alsina A, Makris AM (g), Pak SH, Franco ES, Devidas M, Huffer FW, Kemmer NM, Neff GW.  The detrimental effect of patient’s geography from the Liver Transplant Center: Impact of Hepatitis C. Hepatology October 2012, 56, 505A-505A.

Angiolillo AL, Schore RJ, Reaman GH, Winick NJ, Devidas M, Zheng HW (g), Wood C, Lane AR, Raetz EA, Carroll WL, Hunger SP.  Pharmacokinetic (PK) and pharmacodynamic (PD) properties of SC-PEG e. coli L-asparaginase (EZN-2285) in the treatment of patients with acute lymphoblastic leukemia (ALL): Results from Children’s Oncology Group study AALL07P4. J Clin Oncol; 2012 Jun; 30(15 suppl):#9543. Poster presentation at ASCO 2012.

Larsen E, Raetz EA, Winick NJ, Salzer WL, Nachman JB, Devidas M, Hunger S, Carroll, WL.  Outcome in adolescent and young adulta (AYA) patients compared with younger patients treated for high risk B-precursor acute lymphoblastic leukemia (HR-ALL): a report from the Children’s Oncology Group study AALL0232. J Clin Oncol; 2012 Jun; 30(15 suppl): CRA9508. oral presentation at ASCO 2012.

Sun D (f), Kaeding A, Magoon D, Jones T, Devidas M, Carroll AJ, Heerema NA, Loh ML, Raetz EA, Winick NJ, Carroll WL, Dreyer ZE, Hunger S, Hilden JM, Brown PA.  Safety and biological activity of the FLT3 inhibitor lestaurtinib in infant MLL-rearranged (MLL-r) ALL: Children’s Oncology Group protocol AALL0631. J Clin Oncol; 2012 May; 30(15 suppl): #9548. poster presentation at ASCO 2012.

Asselin BL, Devidas M, Zhou T, Camitta BM, Lipshultz SE. Cardioprotection and safety of dexrazoxane (DRZ) in children treated for newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) or advanced stage lymphoblastic lymphoma (T-LL). J Clin Oncol; 2012 May; 30(15 suppl): #9504. Oral presentation at ASCO 2012.

Lindemulder SJ, Stork LC, Bostrom BC, Lu X, Devidas M, Neglia JP, Kadan-Lottick NS. Trends in body mass index (BMI) during and after treatment for standard risk (SR) acute lymphoblastic leukemia (ALL): A report from the Children’s Oncology Group (COG). J Clin Oncol; 2012 May; 30(15 suppl): #9546. Poster presentation at ASCO 2012.

DuBois SG, Krailo M, Gebhardt M, Donaldson S, Marcus Kj, Dormans J, Shamberger RC, Sailer S, Nicholas R, Healey J, Tarbell N, Devidas M, Meyer J, Granowetter L, Womer R, Bernstein M, Marina N, Grier HE. Evaluation of Local control strategies in patients with localized Ewing Sarcoma of Bone: A Report from the Children’s Oncology Group. J Clin Oncol; 2012 May; 30(15 suppl): #9537. Poster presentation at ASCO 2012.

Dreyer ZE, Salzer WL, Jones T, Devidas M, Rodriguez V, Winick N, Carroll A, Heerema N, Loh M, Raetz E, Carroll WL, Hunger SP.  Intensified PEG-Asparaginase in High Risk Acute Lymphoblastic Leukemia (HR-ALL): Children’s Oncology Group (COG) Study AALL08P1. Pediatric   Blood & Cancer, April 2012; 418: (Oral presentation at ASPHO 2012).

Lau S, Balsamo L, Devidas M, Lu X, Winick N, Hunger S, Carroll W, Maloney K, Kadan-Lottick N.  Family life events in the first year after diagnosis of standard risk (SR) acute lymphoblastic leukemia (ALL): A report from Children’s Oncology Group (COG) AALL0331. Pediatric Blood & Cancer, April 2012; (poster presentation at ASPHO 2012).

Myers RM (f), Balsamo L, Carroll W, Hunger S, Winick N, Devidas M, Lu X, Maloney K, Kadan-Lottick NS.  Emotional and behavioral functioning in the first year after diagnosis of standard risk (SR) acute lymphoblastic leukemia (ALL): A report from Children’s Oncology Group (COG) AALL0331. Pediatric Blood & Cancer, April 2012; (poster presentation). (Poster presentation at ASPHO 2012).

Salzer WL, Jones T, Dreyer ZE, Gore L, Winick NJ, Sung L, Raetz E, Devidas M, Carroll WL, Hunger SP, Hilden JM, Brown P.  Decreased Induction Morbidity and Mortality with Changes to Induction Therapy in Infants with Acute Lymphoblastic Leukemia Enrolled on Children’s Oncology Group (COG) Trial AALL0631. Pediatric Blood & Cancer, April 2012; (Oral presentation at ASPHO 2012).

Wray, L (f), Vujkovic M, McWilliams T, Smith S, Devidas M, Stork L, Aplenc R.  TPMT genotype is not associated with hepatic veno-occlusive disease in Pediatric Acute Lymphoblastic Leukemia. Pediatric   Blood & Cancer, April 2012; 467: (Poster presentation at ASPHO 2012).

John Kairalla, Ph.D.

Kairalla J.A., Coffey C.S., Thomann M.A., and Muller K.E. (2012). Adaptive Trial Designs: A Review of Barriers and Opportunities. Trials, 13:145. DOI: 10.1186/1745-6215-13-145. PMC3519822 (open access http://www.trialsjournal.com/content/pdf/1745-6215-13-145.pdf)

Abdulnour H.A., Williams J.L., Kairalla J.A., and Garin, E.H. (2012). Does hydronephrosis predict the presence of severe vesicoureteral reflux? European Journal of Pediatrics, 171, 1605-1610. PMID:22735979

Mirza A., Mo J., Holt J., Kairalla J.A., Heft M., Ding M., Ahn A. (2012). Is there a relationship between throbbing pain and arterial pulsations? Journal of Neuroscience, 32, 7572-7576. PMC3376713

Cowan L.J., Stechmiller J.K., Rowe M., and Kairalla J.A. (2012). Enhancing Braden Pressure Ulcer Risk Assessment in acutely ill adult veterans.  Wound Repair and Regeneration, 20, 137-148. PMID: 22304370

Eben Kenah, Ph.D.

A. Rahman, M. J. Hossain, S. Sultana, N. Homaira, S. U. Khan, M. Rahman, E. S. Gurley, P. E. Rollin, M. K. Lo, J. A. Comer, L. Lowe, P. A. Rota, T. G. Ksiazek, E. Kenah, Y. Sharker, and S. P. Luby (2012). Date palm sap linked to Nipah virus outbreak in Bangladesh, 2008. Vector-Borne Zoonotic Diseases 12(1): 65-72.

Ira Longini, Ph.D.

Abu-Raddad, LJ, Barnabas, RV, Janes, H, Kublin, JG, Longini, IM and Wasserheit, JN: Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? AIDS ISSN 0269-9370 DOI: 10.1097/QAD.0b013e32835cb927 (2012).

Chao, D.L., Bloom, J.D., Kochin, B.F., Antia, R. and Longini, I.M.: The global spread of drug-resistant influenza. Journal of the Royal Society Interface 9, 648–656 (2012). PubMed PMID: 21865253; PMCID: PMC3284134

Chao, D.L., Halstead, S.B., Halloran, M.E., Longini, I.M.:  Controlling dengue with vaccines in Thailand. PLoS Negl Trop Dis. 2012; 6(10): e1876.doi:10.1371/journal.pntd.0001876 (2012).  PMCID: PMC3493390

Potter, G.E., Handcock, M.S., Longini, I.M. and Halloran, M.E.:  Estimating within-school contact networks to understand influenza transmission. Annals of Applied Statistics 6, 1-26 (2012). PMCID: PMC3359895.

Matrajt, L. and Longini, I.M.:  Critical immune and vaccinated fractions for determining multiple epidemic waves. Epidemics 4, 22-32 (2012). PMCID: PMC3703471 PubMed PMID: 22325011.

Longini, I.M.:  A theoretic framework to consider the effect of immunizing schoolchildren against influenza: Implications for research. Pediatrics Supplement 129, S63-S67 (2012).

Yang, Y, Longini, I.M., Halloran, M.E., Obenchain, V:  A Hybrid EM and Monte Carlo EM Algorithm and Its Application to Analysis of Transmission of Infectious Diseases. Biometrics 68, 1238–49 (2012). PMCID: PMC3402623.

Xiaomin Lu, Ph.D.

Brumback, B., Zheng, H., Lu, X., Bouldin, E., Cannell, M. and Andresen, E. (2012) Doubly Robust Testing and Estimation of Model-Adjusted Effect-Measure Modification with Complex Survey Data, Statistics in Medicine. Vol. 32, No.4, pp.673-84.

Hunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winick, N. J., Reaman, G. H. and Carroll, W. L. (2012) Reply to A. Bleyer et al. Journal of Clinical Oncology. Vol 30, No 32, 4038-9.

Hunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winick, N. J., Reaman, G. H. and Carroll, W. L. (2012) Improved survival for children and adolscents with acute lymphoblastic leukemia from 1990-2005: A Report from the Children’s Oncology Group. Journal of Clinical Oncology. Doi: 10.1200/JCO:2011.37.8018. Vol. 30, No. 14, 1663-9.

Lau S, Balsamo L, Devidas M, Lu X, Winick N, Hunger S, Carroll W, Maloney K, Kadan-Lottick N.  Family life events in the first year after diagnosis of standard risk (SR) acute lymphoblastic leukemia (ALL): A report from Children’s Oncology Group (COG) AALL0331. Pediatric Blood & Cancer, April 2012; (poster presentation at ASPHO 2012).

Lindemulder SJ, Stork LC, Bostrom BC, Lu X, Devidas M, Neglia JP, Kadan-Lottick NS. Trends in body mass index (BMI) during and after treatment for standard risk (SR) acute lymphoblastic leukemia (ALL): A report from the Children’s Oncology Group (COG). J Clin Oncol; 2012 May; 30(15 suppl): #9546. Poster presentation at ASCO 2012.

Myers RM (f), Balsamo L, Carroll W, Hunger S, Winick N, Devidas M, Lu X, Maloney K, Kadan-Lottick NS.  Emotional and behavioral functioning in the first year after diagnosis of standard risk (SR) acute lymphoblastic leukemia (ALL): A report from Children’s Oncology Group (COG) AALL0331. Pediatric Blood & Cancer, April 2012; (poster presentation). (Poster presentation at ASPHO 2012).

Nadeau, S.E., Lu, X., Dobkin, B., Wu, S.S., Dai, Y.E., and Duncan, P.W. (2012) A Prospective Test of the Late Effect of Potentially Anti-Neuroplastic Drugs in a Stroke Rehabilitation Study. International Journal of Stroke. doi:10.1111/j.1747-4949.2012.00920.x.   (PMID: 23088350)

Salzer WL, Winick NJ, Wacker P, Lu X, Devidas M, Shuster JJ, Mahoney DH, Lauer SJ, Camitta BM. Plasma Methotrexate, Red    Blood Cell Methotrexate, and Red    Blood Cell Folate Values and Outcome in Children With Precursor B-acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group. Journal of Pediatric Hematology/Oncology. January 2012 – Volume 34 – Issue 1 – p e1–e7, doi: 10.1097/MPH.0b013e31820ee239

Susan McGorray, Ph.D.

Guo Y, SP McGorray, CE Riggs Jr, HL Logan (2012). Racial disparity in oral and pharyngeal cancer in Florida in 1991-2008: mixed trends in stage of diagnosis. Community Dentistry and Oral Epidemiongy. 41:110-9.

DiGangi BA, JK Levy, B Griffin, SP McGorray, EJ Dubovi, PA Dingman, SJ Tucker (2012). Prevalence of serum antibody titers against feline panleukopenia virus, feline herpesvirus 1, and feline calicivirus in cats entering a Florida animal shelter. Jouranl of the American Veterinary Medical Association. 241:1320-5.

Adewumi AO, C Horton, M Guelmann, V Dixon-Wood, SP McGorray (2012). Parental perception vs. professional assessment of speech changes following premature loss of maxillary primary incisors. Pediatric Dentistry. 34:295-9.

Drake CT, SP McGorray, C Dolce, M Nair, TT Wheeler (2012). Orthodontic tooth movement with clear aligners. ISRN Dentistry. 2012:657973.

McGorray SP, Guo Y, Logan H. Head and neck cancer: trends in Florida 1980-2008. Journal of Public Health Dentistry. (2012) 72(1):68-74.

McGorray SP, Dolce C, Kramer S, Stewart D, Wheeler TT. A randomized, placebo-controlled clinical trial on the effects of recombinant human relaxin on tooth movement and short-term stability. American Journal of Orthodontics & Dentofacial Orthopedics. (2012) 141(2):196-203.

Dolce C. Mansour DA, McGorray SP, Wheeler TT. Intrarater agreement about the etiology of Class II malocclusion and treatment approach. American Journal of Orthodontics & Dentofacial Orthopedics. (2012) 141(1):17-23.

Arlene Naranjo, Ph.D.

Ostler, K.R., Yang, Q., Looney, T.J., Zhang, L., Vasanthakumar, A., Tian, Y., Kocherginsky, M., Raimondi, S.L., DeMaio, J.G., Salwen, H.R., Gu, S., Chlenski, A., Naranjo, A., Gill, A., Peddinti, R., Lahn, B.T., Cohn, S.L., and Godley, L.A. (2012). Truncated DNMT3B Isoform DNMT3B7 Suppresses Growth, Induces Differentiation and Alters DNA Methylation in Human Neuroblastoma. Cancer Research 72(18): 4714-4723. DOI: 10.1158/0008-5472.CAN-12-0886.

Nuchtern, J.G., London, W.B., Barnewolt, C.E., Naranjo, A., McGrady, P.W., Geiger, J.D., Diller, L., Schmidt, M.L., Maris, J.M., Cohn, S.L., and Shamberger, R.C. (2012). A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants, a Children’s Oncology Group Study. Annals of Surgery 256(4): 573–580. DOI: 10.1097/SLA.0b013e31826cbbbd.

DuBois, S.G., Geier, E., Batra, V., Yee, S.W., Neuhaus, J., Segal, M., Martinez, D., Pawel, B., Yanik, G., Naranjo, A., London, W.B., Kreisman, S., Baker, D., Attiyeh, E., Hogarty, M., Maris, J.M., Giacomini, K., and Matthay, K.K. (2012). Evaluation of Norepinephrine Transporter Expression and Avidity for Metaiodobenzylguanidine (MIBG) in Patients with Neuroblastoma: A Report from the Children’s Oncology Group. International Journal of Molecular Imaging, 2012: 8 pages.

Granger, M., Grupp, S.A., Kletzel, M., Kretschmar, C., Naranjo, A., London, W.B., and Diller, L. (2012). Feasibility of a Tandem Autologous Peripheral Blood Stem Cell Transplant Regimen for High Risk Neuroblastoma in a Cooperative Group Setting: A Pediatric Oncology Group Study: A Report from the Children’s Oncology Group. Pediatric Blood & Cancer 59(5): 902–907. DOI: 10.1002/pbc.24207.

Daunic, A.P., Smith, S.W., Garvan, C.W., Barber, B.R., Becker, M.K., Peters, C.D., Taylor, G.G., Van Loan, C.L., Li, W., and Naranjo, A.H. (2012). Reducing Developmental Risk for Emotional/Behavioral Problems: A Randomized Controlled Trial Examining the Tools for Getting Along Curriculum. Journal of School Psychology 50(2): 149-166. DOI:10.1016/j.jsp.2011.09.003.

Turnbull, C., Perdeaux, E.R., Pernet, D., Naranjo, A., Renwick, A., Seal, S., Munoz-Xicola, R.M., Hanks, S., Slade, I., Zachariou, A., Warren-Perry, M., Ruark, E., Gerrard, M., Hale, J., Hewitt, M., Kohler, J., Lane, S., Levitt, G., Madi, M., Morland, B., Neefjes, V., Nicholdson, J., Picton, S., Pizer, B., Ronghe, M., Stevens, M., Traunecker, H., Stiller, C.A., Pritchard-Jones, K., Dome, J., Grundy, P., and Rahman, N. (2012). A Genome-Wide Association Study Identifies Susceptibility Loci for Wilms Tumor. Nature Genetics 44(6): 681–684. DOI: 10.1038/ng.2251.

Samuel Wu, Ph.D.

Corti M, McGuirk TE, Wu SS, Patten C. (2012). Differential Effects of Power Training Versus Functional Task Practice on Compensation and Restoration of Arm Function After Stroke. Neurorehabilitation and Neural Repair. 26(7):842-54. (PMID: 22357633)

Oyama G, Foote KD, Jacobson CE 4th, Velez-Lago F, Go C, Limotai N, Zeilman PR, Romrell J,Wu SS, Neal D, Okun MS. (2012). GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson’s disease. Parkinsonism Relat Disord. 18(7):814-8. (PMID: 22525365)

Hassan A., Wu SS, Schmidt P, Malaty IA, Dai YF, Miyasaki JM, Okun MS. (2012). What are the issues facing Parkinson’s disease patients at ten years of disease and beyond?: Data from the NPF-QII study. Parkinsonism Relat Disord. Suppl 3:S10-4. (PMID: 22776044)

Nadeau SE, Lu X, Dobkin BH, Wu SS, Dai YE, Duncan PW, for The LEAPS Investigative Team. (2012). A prospective test of the late effects of potentially antineuroplastic drugs in a stroke rehabilitation study. International Journal of Stroke. 1747-49. (PMID: 23088350)

Day, K. V., Kautz, S. A.,Wu, S. S., Suter, S. T., Behrman, A. L. (2012). Foot placement variability as a walking balance mechanism post-spinal cord injury. Clinical Biomechanics.27(2): 145-50.(PMID:22000699)

Tilson, J. K., Wu, S. S., Cen, S., Feng, Q., Rose, D. K., Behrman, A. L., Azen, S. P., Duncan, P. W. for The LEAPS Investigative Team. (2012). Characterizing and identifying risk for falls in the leaps study: a randomized clinical trial of interventions to improve walking post-stroke. Stroke. 43(2): 446-52. (PMID: 22246687)

George S. Z., Childs J. D., Teyhen D. S., Wu, S. S., Wright A. C., Dugan J. L., Robinson E. (2012). Predictors of occurrence and severity of first time low back pain episodes: findings from a military inception cohort. it PLoS One 7(2):e30597. (PMID: 22355317)

Tao L, Wu SS, Chen SG, Yang MCK. (2012). Generalized energy-efficient algorithms for the RFID estimation problem. ACM/IEEE Transcation On Networking. 20(6): 1978 – 1990.

Yang Yang, Ph.D.

Yang, Y., Longini, IM, Halloran, ME Obenchain, V. (2012) A hybrid EM and Monte Carlo EM algorithm and its application to analysis of transmission of infectious diseases. Biometrics 2012 Dec; 68(4):1238-49. DOI: 10.1111/j.1541-0420.2012.01757.x

Yang Y. and DeGruttola, V. Resampling-based Methods for Testing Equality of Covariance/Correlation Matrices. International Journal of Biostatistics. 2012;8 (1): Article 13.